We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+5.58%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$1.01B
AUM Growth
-$40.3M
Cap. Flow
-$81.7M
Cap. Flow %
-8.12%
Top 10 Hldgs %
53.94%
Holding
5,392
New
831
Increased
1,118
Reduced
1,635
Closed
1,628

Sector Composition

Rank Sector Weight
1 Financials 3.47%
2 Industrials 2.67%
3 Technology 2.45%
4 Consumer Discretionary 2.4%
5 Materials 2.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CD
2851
Chaince Digital Holdings
CD
$436M
$3K ﹤0.01%
36
MIND icon
2852
MIND Technology
MIND
$43M
$3K ﹤0.01%
77
-194
-72% -$6.19K
MSD
2853
Morgan Stanley Emerging Markets Debt Fund
MSD
$148M
$3K ﹤0.01%
+332
New +$3.21K
NEXT icon
2854
NextDecade
NEXT
$1.91B
$3K ﹤0.01%
300
-317
-51% -$3.18K
NLY icon
2855
Annaly Capital Management
NLY
$17.6B
$3K ﹤0.01%
+80
New +$3.47K
NML
2856
Neuberger Energy Infrastructure and Income Fund Inc
NML
$610M
$3K ﹤0.01%
285
+244
+595% +$2.13K
NOAH
2857
Noah Holdings
NOAH
$592M
$3K ﹤0.01%
+100
New +$2.61K
NSYS icon
2858
Nortech Systems
NSYS
$33.8M
$3K ﹤0.01%
791
+703
+799% +$2.72K
NWG icon
2859
NatWest
NWG
$76B
$3K ﹤0.01%
536
-9,913
-95% -$52.9K
OEC icon
2860
Orion
OEC
$364M
$3K ﹤0.01%
174
-1,111
-86% -$19.4K
OMF icon
2861
OneMain Financial
OMF
$7.56B
$3K ﹤0.01%
95
+61
+179% +$1.76K
OPHC icon
2862
OptimumBank Holdings
OPHC
$124M
$3K ﹤0.01%
+540
New +$2.54K
OTLK icon
2863
Outlook Therapeutics
OTLK
$141M
$3K ﹤0.01%
4
PACB icon
2864
Pacific Biosciences
PACB
$357M
$3K ﹤0.01%
281
-8,883
-97% -$74.3K
PAVM icon
2865
PAVmed
PAVM
$37.2M
$3K ﹤0.01%
+1
New +$6.36K
PBT
2866
Permian Basin Royalty Trust
PBT
$1.52B
$3K ﹤0.01%
+400
New +$2.79K
PDEX icon
2867
Pro-Dex
PDEX
$214M
$3K ﹤0.01%
558
-118
-17% -$615
PFD
2868
Flaherty & Crumrine Preferred and Income Fund
PFD
$146M
$3K ﹤0.01%
+172
New +$2.69K
PGZ
2869
Principal Real Estate Income Fund
PGZ
$68.3M
$3K ﹤0.01%
194
-396
-67% -$7.02K
PJT icon
2870
PJT Partners
PJT
$4.46B
$3K ﹤0.01%
106
-664
-86% -$16.6K
PNF
2871
DELISTED
PIMCO New York Municipal Income Fund
PNF
$3K ﹤0.01%
+200
New +$2.73K
PNI
2872
PIMCO New York Municipal Income Fund II
PNI
$78M
$3K ﹤0.01%
211
+100
+90% +$1.4K
PVBC
2873
DELISTED
Provident Bancorp
PVBC
$3K ﹤0.01%
+400
New +$3.14K
PYN
2874
DELISTED
PIMCO New York Municipal Income Fund III
PYN
$3K ﹤0.01%
+296
New +$3.36K
RAND icon
2875
Rand Capital
RAND
$30.1M
$3K ﹤0.01%
88
+10
+13% +$313

Similar funds

Tower Research Capital (TRC)'s Q3 2016 Portfolio in Review

As of Q3 2016, Tower Research Capital (TRC) held 5,392 positions worth $1.01B, down 3.8% from $1.05B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Tower Research Capital (TRC) withdrew a net $81.7M in Q3 2016, closing 1,628 positions and reducing 1,635 holdings. Its most notable exit was iShares Biotechnology ETF, an estimated $26.8M position sold in full.

By sector, the portfolio is most concentrated in Financials at 3.5% of assets, down from 6.2% a quarter earlier, followed by Industrials and Technology.

Against the trend, Tower Research Capital (TRC) opened a new position in Vanguard S&P 500 ETF worth $14.7M.

  • Tower Research Capital (TRC)'s largest Q3 2016 buy was Vanguard S&P 500 ETF: 74,203 shares worth $14.7M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2016, an estimated $303M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2016 reduction was State Street Consumer Discretionary Select Sector SPDR ETF, cutting an estimated $24.2M.
  • Tower Research Capital (TRC) fully exited iShares Biotechnology ETF in Q3 2016, selling an estimated $26.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 54% of its $1.01B portfolio in Q3 2016.
  • Tower Research Capital (TRC) opened 831 new positions and closed 1,628 in Q3 2016.
  • Tower Research Capital (TRC)'s portfolio value fell 3.8% quarter-over-quarter to $1.01B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2016, filed 8 Nov 2016.